Boston Scientific Cardiac Diagnostic Technologies, Inc.

Boston Scientific Cardiac Diagnostic Technologies, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on January 23, 2026 and the most recent on January 23, 2026 (BodyGuardian Remote Monitoring System (BGRMS v3.0)). Its most common review panel is Cardiovascular (1 device).